Cipher Pharmaceuticals
Mississauga
About Cipher Pharmaceuticals
Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs. They search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Their core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $55.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2023)
- Ticker: tsx:CPH
- Website: cipherpharma.com
- Phone: 905-602-5840
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cipher-pharmaceuticals-217109 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.